Natural Alternatives Posts 26% Revenue Growth In Q4

Natural Alternatives International Inc NAII reported fourth-quarter FY21 sales growth of 26.5% year-on-year, to $44.4 million.
The private-label contract manufacturing sales rose 21.2% Y/Y. The increase in contract manufacturing sales was driven by higher sales of immune and wellness products.
Gross profit climbed 21.4% Y/Y to $7.9 million, with the margin contracting 70 basis points to 17.9%.
The operating margin was 7.9%, and operating income for the quarter rose 68.7% to $3.5 million.
EPS of $0.47 increased 74% Y/Y.
Natural Alternatives held $32.1 million in cash and equivalents as of June 30, 2021.
The company expects some challenges related to supply chain and staffing in 1H and the manufacturing challenges to be substantially resolved during 2H of FY22.
Outlook: Natural Alternatives sees FY22 sales growth of 5.0% - 10.0% from FY21.
Price Action: NAII shares closed lower by 4.76% at $14.20 on Monday.

Momentum14.32

Growth17.46

QualityNot Available

Value88.09

Short

Medium

Long

Earnings Calendar